Healthcare -
Biotechnology - NASDAQ - US
$ 12.08
1.94 %
$ 39.3 M
Market Cap
-0.71
P/E
Price Target
Average
272.52%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
63.82%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Surrozen, Inc.
Wall Street analysts predict an average 1-year price target for SRZN of $45 , with forecasts ranging from
a
low of
$45 to a high of $45 .
SRZN Lowest Price Target
Wall Street Target
45 USD
272.52%
SRZN Average Price Target
Wall Street Target
45 USD
272.52%
SRZN Highest Price Target
Wall Street Target
45 USD
272.52%
REVENUE FORECAST
Revenue Forecast Chart SRZN
EBIT FORECAST
EBIT Forecast Chart SRZN
NET INCOME FORECAST
Net Income Chart SRZN